Search results
Author(s):
Vivek Reddy
Added:
1 year ago
HRS 25 - First-in-human study demonstrates successful implantation of a novel leadless pacemaker with clinically acceptable intraprocedural electrical performance and safety.We are joined by Dr Vivek Reddy (Icahn School of Medicine at Mount Sinai, New York, US) to discuss the findings from a feasibility study investigating the safety and performance of a novel helix-based leadless pacemaker with…
View more
Author(s):
Added:
6 days ago
HRS Congress 2026 – Dr Shephal Doshi (Pacific Heart Institute, Santa Monica, CA) joins us to discuss findings from the LEAP 2 Chronic Early Feasibility Study, evaluating the safety and performance of the AVEIR CSP Leadless Pacemaker System in patients with standard pacing indications.This prospective, single-arm feasibility study enrolled patients requiring pacemaker implantation to assess…
View more
Author(s):
Elad Anter
Added:
2 weeks ago
HRS Congress 2026 — Prof Elad Anter (Yitzhak Shamir Medical Center, Beer Yakov, IL) joins us to discuss findings from a study investigating reentry at patient-specific atrial regions characterised by steep repolarisation gradients as a mechanism of atrial fibrillation in humans.Interview Questions:What is the current state of debate around reentry as a mechanism of AF, and what has been missing…
View more
HRS 25: FIH VCAS Trial
Author(s):
Vivek Reddy
Added:
1 year ago
Video
Pradeep Natarajan
Job title: Director of Preventive Cardiology
Author
Author(s):
Mattias Duytschaever
Added:
1 year ago
HRS 2025 - First-in-human three-month results from a contact force-sensing catheter integrated with 3D mapping to treat paroxysmal atrial fibrillation (PAF) show potential for high acute effectiveness and a promising safety profile.Dr Mattias Duytschaever (St Jan Hospital, Bruges, BE) joins us to discuss the three-month findings from the first-in-human Omny-IRE study (NCT05971693; Biosense…
View more
Arnold von Eckardstein
Job title: Professor
Author
Added:
3 months ago
Source:
AF Symposium
AF Symposium has announced a series of late-breaking scientific sessions scheduled for February 2026, featuring first-in-human data and pivotal trial results across pulsed field ablation (PFA), left atrial appendage (LAA) therapies, and advanced mapping technologies.These sessions will showcase cutting-edge clinical science presented by leading international investigators, with a strong focus on…
View more